Intravenous lidocaine in central pain: A double-blind, placebo- controlled, psychophysical study

Neurology

Volumn 54, Issue 3, 2000, Pages 564-574

  Attal, N ^a   Gaude V ^a   Brasseur, L ^a   Dupuy, M ^a   Guirimand, F ^a   Parker, F ^b   Bouhassira, Didier ^a,c  

^a HÔPITAL AMBROISE PARÉ   (France)

^b HÔpital Bicêtre   (France)

^c INSERM   (France)

Author keywords

Central pain; Neuropathic pain; Placebo controlled study; Quantitative sensory tests; Systemic lidocaine

Indexed keywords

LIDOCAINE; PLACEBO;

ADULT; AGED; ALLODYNIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSARTHRIA; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; HYPERALGESIA; MALAISE; MALE; NAUSEA; PAIN ASSESSMENT; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; SPINAL CORD INJURY; STROKE; TINNITUS; VERTIGO; VISUAL IMPAIRMENT; VOMITING; XEROSTOMIA;

EID: 0034620497     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.54.3.564     Document Type: Article

References (46)

1. Casey KL, ed. Pain and central nervous system disease. The central pain syndromes. New York: Raven, 1991.
2. Gonzales GR. Central pain: diagnosis and treatment strategies. Neurology 1995;45(suppl 9):S11-S16.
3. Bach FW, Jensen TS, Kastrup J, Sitgsby B, Dejgard A. The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy. Pain 1990;40:29-34.
4. Kastrup J, Petersen P, Dejgard A, Angelo H, Hilsted J. Intravenous lidocaine infusion. A new treatment of chronic painful diabetic neuropathy? Pain 1987;28:69-75.
5. Marchettini P, Lacerenza M, Marangoni C, Pellegata G, Sotgiu ML, Smirne S. Lidocaine test in neuralgia. Pain 1992;48: 377-382.
6. Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991;41:1024-1028.
7. Wallace MS, Dyck JB, Rosi SR, Yaksh TL. Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury. Pain 1996;66:69-77.
8. Awerbuch GI, Sandyk R. Mexiletine for thalamic pain syndrome. Int J Neurosci 1990;55:129-133.
9. Bakonja M, Gombar K. Response of central pain syndromes of intravenous lidocaine. J Pain Symptom Manage 1992;7:172-178.
10. Edmonson EA, Simpson RK, Stubler DK, Beric A. Systemic lidocaine therapy for poststroke pain. Southern Med J 1993; 86:1093-1096.
11. Chiou-Tan FY, Tuel SM, Johnson JC, Priebe MM, Hirsh DD, Strayer JR. Effect of mexiletine on spinal cord injury dysesthetic pain. Am J Phys Med Rehabil 1996;75:84-87.
12. Hansson P, Lindblom U. Hyperalgesia assessed with quantitative sensory testing in patients with neurogenic pain. In: Willis WD, ed. Hyperalgesia and allodynia. New York: Raven, 1992:335-343.
13. Attal N, Brasseur B, Parker F, Chauvin M, Bouhassira D. Effects of the anticonvulsant gabapentin on neuropathic peripheral and central pain: a pilot study. Eur Neurol 1998;40: 191-200.
14. Attal N, Brasseur L, Chauvin M, Bouhassira D. Effects of single and repeated applications of eutectic mixture of local anesthetics (EMLA) cream on spontaneous and evoked pains in patients with postherpetic neuralgia. Pain 1999;81:203-210.
15. Eide PK, Stubhaug A, Stenehjem AE. Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation. Neurosurgery 1995; 37:1080-1087.
16. Felsby S, Nielsen J, Arendt-Nielsen L, Jensen TS. NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride. Pain 1995;64:283-291.
17. Attal N, Parker F, Dupuy M, Gaudé V, Brasseur L, Bouhassira D. Effects of intravenous lidocaine on spontaneous and evoked pains in patients with CNS injury: a double-blind randomized placebo controlled study. San Diego: American Pain Society, November 1998.
18. Fruhstorfer H, Lindblom U, Schmidt WG. Method for quantitative estimation of thermal thresholds in patients. J Neurol Neurosurg Psychiatry 1976;39:1071-1075.
19. Kalso E, Tramer MR, McQuay HJ, Moore RA. Systemic local-anaesthetic-type drugs in chronic pain: a systematic review. Eur J Pain 1998;2:3-14.
20. Edwards WT, Habib F, Burney RG, Begin G. Intravenous lidocaine in the management of various chronic pain states. Reg Anesth 1985;10:1-6.
21. Galer BS, Harle J, Rowbotham M. Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: a prospective study. J Pain Symptom Manage 1996;12: 161-167.
22. Boas RA, Covino RB, Shahnarian A. Analgesic responses to IV lidocaine. Br J Anaesth 1982;54:501-505.
23. Ferrante FM, Paggioli J, Cherukuri S, Arthur GR. The analgesic response to intravenous lidocaine in the treatment of neuropathic pain. Anesth Analg 1996;82:91-97.
24. Galer BS, Miller KV, Rowbotham MC. Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury. Neurology 1993;43:1233-1235.
25. Chaplan SR, Bach FW, Shafer SL, Yaksh TL. Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats. Anesthesiology 1995;775-785.
26. Hao JX, Yu YX, Seiger A, Wiesenfeld-Hallin Z. Systemic tocainide relieves mechanical hypersensitivity and normalizes the responses of hypersensitive dorsal horn wide dynamic range neurons after transient spinal cord ischemia in rats. Exp Brain Res 1992;229-235.
27. Xu XJ, Hao JX, Seiger A, Arner S, Lindblom U, Wiesenfeld-Hallin Z. Systemic mexiletine relieves chronic allodynia-like symptoms in rats with ischemic spinal cord injury. Anesth Analg 1992;74:649-652.
28. Gracely RH. Experimental pain models. In: Max M, Portenoy R, Laska E, eds. Advances in pain research and therapy: the design of analgesic trials. New York: Raven Press, 1991;18: 33-47.
29. Abdi S, Hyun D, Chung JM. The anti-allodynic effects of amitriptyline, gabapentin and lidocaine in a rat model of neuropathic pain. Anesth Analg 1998;87:1360-1366.
30. Abram SE, Yaksh TL. Systemic lidocaine blocks nerve-induced hyperalgesia and nociceptor-driven spinal sensitization in the rat. Anesthesiology 1994;80:383-391.
31. Chabal C, Jacobson L, Russel LC, Burchiel KJ. Pain responses to perineuromal injection of normal saline, gallamine, and lidocaine in humans. Pain 1989;36:321-325.
32. Devor M, Wall PD, Catalan N. Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction. Pain 1992;48:261-268.
33. Tanelian DL, Brose WG. Neuropathic pain can be relieved by drugs that are use-dependent sodium channel blockers: lidocaine, carbamazepine, and mexiletine. Anesthesiology 1991; 74:949-951.
34. Usubiaga J, Moya F, Wikinski J. Relationship between the passage of local anaesthetic across the blood brain barrier and their effects on the central nervous system. Br J Anesth 1967; 39:943-947.
35. Tsai PS, Buerkle H, Huang LT, Lee TC, Yang LC, Lee JH. Lidocaine concentrations in plasma and cerebrospinal fluid after systemic bolus administrations in humans. Anesth Analg 1998;87:601-604.
36. Nagy I, Woolf CJ. Lignocaine selectively reduces C fiber-evoked neuronal activity in rat spinal cord in vitro by decreasing N-methyl-D-aspartate and neurokinin receptor-mediated post-synaptic depolarizations: implications for the development of novel centrally acting analgesics. Pain 1996;64:59-70.
37. Sotgiu ML, Lacerenza M, Marchettini P. Selective inhibition by systemic lidocaine of noxious evoked activity in rat dorsal horn neurons. Neuroreport 1991;2:425-428.
38. Woolf CJ, Wiesenfeld-Hallin Z. The systemic administration of local anesthetics produces a selective depression of C-afferent fiber evoked activity in the spinal cord. Pain 1985; 23:361-374.
39. Hao JX, Kupers R, Wiesenfeld-Hallin Z. Systemic lidocaine induces expansion of the receptive field of spinal dorsal horn neurons in rats. Exp Brain Res 1998;118:431-434.
40. Sotgiu ML, Lacerenza M, Marchettini P. Effects of systemic lidocaine on dorsal horn neuron hyperactivity following chronic peripheral nerve injury in rats. Somatosens Mot Res 1992;9:227-233.
41. Sotgiu ML, Biella G, Castagna A, Lacerenza M, Marchettini P. Different time-courses of iv lidocaine effect on ganglionic and spinal units in neuropathic rats. Neuroreport 1994;14: 873-876.
42. Biella G, Sotgiu ML. Central effects of systemic lidocaine mediated by glycine spinal receptors: an iontophoretic study in the rat spinal cord. Brain Res 1993;603:201-206.
43. Biella G, Lacerenza M, Marchettini P, Sotgiu ML. Diverse modulation by systemic lidocaine of iontophoretic NMDA and quisqualic acid induced excitations on rat dorsal horn neurons. Neurosci Lett 1993;23:207-210.
44. Pertovaara A, Wei H, Hamalainen MM. Lidocaine in the rostroventromedial medulla and the periaqueductal gray attenuates allodynia in neuropathic rats. Neurosci Lett 1996;218: 127-130.
45. Leijon G, Boivie J. Central post-stroke pain: a controlled trial of amitriptyline and carbamazepine. Pain 1989;36:27-36.
46. Swerdlow M, Cundill JG. Anticonvulsant drugs used in the treatment of lancinating pain: a comparison. Anaesthesia 1981;36:1129-1132.